Author | Euan Walpole, MBBS


Paclitaxel as First-Line Treatment for Metastatic Breast Cancer

April 01, 1997

ByJames F. Bishop, MD, MBBS|Martin H. Tattersall, MD, MB|Joanna Dewar, MBBS|Guy C. Toner, MD, MBBS|Ian N. Olver, MD, MBBS|Stephen Ackland, MBBS|Ian Kennedy, MBBS|David Goldstein, MBBS|Howard Gurney, MBBS|Euan Walpole, MBBS|John Levi, MD, MBBS|Jennifer Stephenson, MSc

When administered as a single agent in pretreated patients with advanced breast cancer, paclitaxel (Taxol) exhibits remarkable antitumor activity. This trial was undertaken to compare paclitaxel with standard